Pharmala Biotech Holdings Inc. (MDMA.CN)
Canadian Sec · CAD · Healthcare · Biotechnology
CA$0.165 (+0.00%) as of
Key statistics
- Market cap
- 18.18M
- EPS (TTM)
- -0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.0850 – 0.3300
- Beta
- 0.87
- Revenue (TTM)
- 1.27M
- Profit margin
- -126.87%
- Volume
- 64.00k
About Pharmala Biotech Holdings Inc.
Pharmala Biotech Holdings Inc., a biotechnology company, engages in the development, manufacture, and sale of MDMA and MDXX class molecules in service to the burgeoning clinical research community. It offers its MDMA drug active pharmaceutical ingredients under the LaNeo brand. The company is headquartered in Vancouver, Canada.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Vancouver, BC, Canada
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.